ASW

N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide

ASW is found in 1 entries

ASW as free ligands, exist in 1 entries. Examples include 4G0U,

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
Identifiers N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide
Synonyms Amsacrine
Formula C21 H19 N3 O3 S
Molecular Weight 393.46 g/mol
Type non-polymer
Isomeric SMILES COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
InChI InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChI Key XCPGHVQEEXUHNC-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 47
Chiral Atom Count 0
Chiral Atoms
Bond Count 50
Aromatic Bond Count 22

Drug Info: DrugBank

DrugBank ID DB00276   (Stereoisomeric match)
Name Amsacrine
Groups approved
Description Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]
Synonyms
  • 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide
  • 4'-(9-Acridinylamino)methanesulfon-m-anisidide
  • 4'-(9-Acridinylamino)methanesulfon-meta-anisidide
  • 4'-(9-Acridinylamino)methanesulphon-m-anisidide
  • Acridinyl anisidide
Brand Names
  • Amsa Pd Inj 50mg/ml
  • AMSA P-D
  • Amekrin
  • Amsidine
  • Amsidyl
Affected Organism Humans and other mammals
Indication For treatment of acute myeloid leukaemia.
Pharmacology Amsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Mechanism of action Amsacrine binds to DNA through intercalation and external binding. It has a base specificity for A-T pairs. Rapidly dividing cells are two to four times more sensitive to amsacrine than are resting cells. Amsacrine appears to cleave DNA by inducing double stranded breaks. Amsacrine also targets and inhibits topoisomerase II. Cytotoxicity is greatest during the S phase of the cell cycle when topoisomerase levels are at a maximum.
Route of administration intravenous
Categories
  • Antineoplastic Agents
  • Intercalating Agents
ATC-Code L01XX01
AHFS-Code 10:00.00
CAS number 51264-14-3
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682